Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 2 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 22 most recent Form 4 transactions.
| Aug 7 | CRNX | Crinetics Pharmaceuticals,… | MEXER◆ | 4,422 | — | — | — | Open the original filing on SEC.gov |
| Aug 7 | CRNX | Crinetics Pharmaceuticals,… | MEXER◆ | 3,969 | — | — | — | Open the original filing on SEC.gov |
| Aug 7 | CRNX | Crinetics Pharmaceuticals,… | MEXER | 4,995 | $20.02 | $100K | +1.2% | Open the original filing on SEC.gov |
| Aug 7 | CRNX | Crinetics Pharmaceuticals,… | MEXER | 6,542 | $15.29 | $100K | +1.6% | Open the original filing on SEC.gov |
| Aug 7 | CRNX | Crinetics Pharmaceuticals,… | MEXER | 4,422 | $22.61 | $100K | +1.1% | Open the original filing on SEC.gov |
| Aug 7 | CRNX | Crinetics Pharmaceuticals,… | MEXER | 3,969 | $25.19 | $100K | +1.0% | Open the original filing on SEC.gov |
| May 29 | CRNX | Crinetics Pharmaceuticals,… | GGIFT | 111,100 | — | — | — | Open the original filing on SEC.gov |
| May 29 | CRNX | Crinetics Pharmaceuticals,… | GGIFT | 111,100 | — | — | — | Open the original filing on SEC.gov |
| May 29 | CRNX | Crinetics Pharmaceuticals,… | GGIFT | 111,100 | — | — | -99.1% | Open the original filing on SEC.gov |
| May 29 | CRNX | Crinetics Pharmaceuticals,… | GGIFT | 111,100 | — | — | -49.8% | Open the original filing on SEC.gov |
| May 29 | CRNX | Crinetics Pharmaceuticals,… | GGIFT | 111,100 | — | — | — | Open the original filing on SEC.gov |
| May 29 | CRNX | Crinetics Pharmaceuticals,… | GGIFT | 111,100 | — | — | — | Open the original filing on SEC.gov |
| May 29 | CRNX | Crinetics Pharmaceuticals,… | GGIFT | 111,100 | — | — | -21.5% | Open the original filing on SEC.gov |
| May 29 | CRNX | Crinetics Pharmaceuticals,… | GGIFT | 111,100 | — | — | -17.7% | Open the original filing on SEC.gov |
| May 29 | CRNX | Crinetics Pharmaceuticals,… | GGIFT | 80,000 | — | — | — | Open the original filing on SEC.gov |
| May 29 | CRNX | Crinetics Pharmaceuticals,… | GGIFT | 222,200 | — | — | +22,220% | Open the original filing on SEC.gov |
| May 29 | CRNX | Crinetics Pharmaceuticals,… | GGIFT | 222,200 | — | — | +54.9% | Open the original filing on SEC.gov |
| May 29 | CRNX | Crinetics Pharmaceuticals,… | GGIFT | 80,000 | — | — | -36.9% | Open the original filing on SEC.gov |
| May 29 | CRNX | Crinetics Pharmaceuticals,… | GGIFT | 222,200 | — | — | -50.6% | Open the original filing on SEC.gov |
| May 29 | CRNX | Crinetics Pharmaceuticals,… | GGIFT | 222,200 | — | — | -33.6% | Open the original filing on SEC.gov |